FDA Grants Rare Pediatric Disease Designation (RPDD) to volasertib for rhabdomyosarcoma

by Oncoheroes Biosciences
  • 4 years ago

Oncoheroes Biosciences, a biotech focused on advancing new therapies for childhood cancer, is pleased to announce that the United States Food and Drug Administration (FDA) has granted the designation ...

Read more

Attending ASEBIO Investors Day, Online

by Oncoheroes Biosciences

Oncoheroes’ CEO, Ricardo Garcia, is attending Asebio Investor Day, a digital event organized by the “Asociación Española de Bioempresas“.

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New findings for a better understanding ...

by Universitat de Barcelona

A study published in Pediatric Neurology provides a better understandi...

Photos Stream